Table 1.
Cancer Type | Minimum Scenario | Maximum Scenario | ||||
---|---|---|---|---|---|---|
1st Year USPSTF Recommendation |
Eligible Population |
Life-Years Gained per Screened Individual | 1st Year USPSTF Recommendation | Eligible Population | Life-Years Gained per Screened Individual | |
Breast | 1996 | Women; age 50–69 y | 0.029 [22] | 1996 | Women, age 40 + y | 0.044 [22] |
Colorectal | 1996 | Age 50–75 y | Flex sig + FITa: 0.009 [23] | 2002 | Age 45–75 y | Colonoscopy: 0.022 [23] |
Cervical | 1996 | Women; age 21–65 y |
PAPb: 0.089 [24] |
1996 | Women; age 21–65 y | 21–30 PAP; 30–65 cotestingc: 0.096 [24] |
Lung | 2014 | Current smoker or former smoker; age 50–80 y | 0.0316 [25] | Limited benefit evidence, same as minimum scenario |
aFlex sig: flexible sigmoidoscopy, an endoscopic procedure that allows physician to examine the rectum and lower colon
bPAP: a Pap smear or Pap test is a screening test for cervical cancer
cCotesting: combination of PAP and human papilloma virus testing
FIT, fecal immunochemical test; USPSTF, US Preventive Services Task Force